Inventor · disambiguated record
Carrie Brownstein
Also filed as: BROWNSTEIN CARRIE
3 granted patents·3 pending applications·10 citations·filing 2015–2023
63Inventor score
Files withREGENERON PHARMA6
Top patents by PatentIndex Score
6 records- 0194US12054557B2Combination of anti-PD-1 antibodies and bispecific anti-CD20/anti-CD3 antibodies to treat cancerREGENERON PHARMA·Filed 2021·Granted Aug 6, 2024·4 cites·33 claims
- 0286US11590223B2Dosing strategy that mitigates cytokine release syndrome for therapeutic antibodiesREGENERON PHARMA·Filed 2019·Granted Feb 28, 2023·4 cites·53 claims
- 0379US10662244B2Methods for tumor treatment using CD3XCD20 bispecific antibodyREGENERON PHARMA·Filed 2015·Granted May 26, 2020·2 cites·17 claims
- 0467US2023165959A1Dosing Strategy that Mitigates Cytokine Release Syndrome for Therapeutic AntibodiesREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0545US2017174779A1Combination of Anti-PD-1 Antibodies and Anti-CD20/Anti-CD3 Antibodies to Treat CancerREGENERON PHARMA·Filed 2016·Application pending·0 cites
- 0638US2017174781A1Bispecific Anti-CD20/Anti-CD3 Antibodies to Treat Acute Lymphoblastic LeukemiaREGENERON PHARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carrie Brownstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →